Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

EBI3 Antikörper

Der Maus Monoklonal Anti-EBI3-Antikörper wurde für WB, ELISA und IP validiert. Er ist geeignet, EBI3 in Proben von Maus zu detektieren. Es sind 2+ Publikationen verfügbar.
Rockland
Produktnummer ABIN7540536
Hersteller Produkt- Nr.: dup_210-301-b66s_dup

Kurzübersicht für EBI3 Antikörper (ABIN7540536)

Target

Alle EBI3 (IL-27b) Antikörper anzeigen
EBI3 (IL-27b) (Interleukin-27 subunit beta (IL-27b))

Reaktivität

  • 65
  • 32
  • 5
  • 1
  • 1
Maus

Wirt

  • 62
  • 16
  • 8
  • 1
Maus

Klonalität

  • 62
  • 25
Monoklonal

Konjugat

  • 48
  • 11
  • 6
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser EBI3 Antikörper ist unkonjugiert

Applikation

  • 58
  • 41
  • 21
  • 13
  • 13
  • 13
  • 9
  • 9
  • 6
  • 5
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunoprecipitation (IP)

Klon

V1-4C4-22
  • Hersteller Produkt- Nr.

    dup_210-301-b66s_dup

    Hersteller

    Rockland

    Verwendungszweck

    IL-35 EBI3 Antibody

    Kreuzreaktivität (Details)

    This antibody is specific for mouse EBI3 protein.

    Aufreinigung

    Anti-Mouse EBI-3 (MOUSE) Monoclonal Antibody was purified from mouse ascites by Protein A chromatography followed by extensive dialysis against the buffer stated above.

    Sterilität

    Sterile filtered

    Immunogen

    Anti-EBI-3 (MOUSE) Monoclonal Antibody was produced in mouse by repeated immunizations with mature full length recombinant mouse EBI-3 produced in E.coli followed by hybridoma development.

    Isotyp

    IgG2b
  • Applikationshinweise

    Neutralization_Dilution: 10 μg/mL

    Immunoprecipitation_Dilution: 1 μg/mL

    ELISA_Dilution: 1:10,000

    Western_Blot_Dilution: 1:1000

    Other: User Optimized

    Kommentare

    Suggested Applications: Cellular Assay
    Anti-Mouse EBI-3 antibody has been tested for use in ELISA and western Blot and is suitable for IP and Neutralization. Specific conditions for reactivity should be optimized by the end user.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2

    Stabilizer: None

    Preservative: 0.01 % (w/v) Sodium Azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store vial at -20° C or below prior to opening. This vial contains a relatively low volume of reagent (25 μL). To minimize loss of volume dilute 1:10 by adding 225 μL of the buffer stated above directly to the vial. Recap, mix thoroughly and briefly centrifuge to collect the volume at the bottom of the vial. Use this intermediate dilution when calculating final dilutions as recommended below. Store the vial at -20°C or below after dilution. Avoid cycles of freezing and thawing.

    Haltbarkeit

    12 months
  • Feng, Zhang, Ding, Chen, Wang, Wang, Zou, Sheng, Chen, Pang, Marshall, Shi, Nedergaard, Li, Xiao: "B lymphocytes ameliorate Alzheimer's disease-like neuropathology via interleukin-35." in: Brain, behavior, and immunity, Vol. 108, pp. 16-31, (2023) (PubMed).

    Zhang, Li, Zhou, Zhang, Wu, Xu, Shen, An, Shen, Yang, Zhang, Tao: "The Unknown Aspect of BAFF: Inducing IL-35 Production by a CD5+CD1dhiFcγRIIbhi Regulatory B-Cell Subset in Lupus." in: The Journal of investigative dermatology, Vol. 137, Issue 12, pp. 2532-2543, (2017) (PubMed).

  • Target

    EBI3 (IL-27b) (Interleukin-27 subunit beta (IL-27b))

    Andere Bezeichnung

    Ebi3

    Hintergrund

    Mouse anti-EBI3 antibody, mouse anti-IL-35 antibody, Epstein-Barr virus induced 3 protein, Interleukin-27 subunit beta, IL-27 subunit beta, IL-27B, Epstein-Barr virus-induced gene 3 protein, EBV-induced gene 3 protein, EBI-3, EBI3, IL-35, IL35,The cytokine Interleukin 27 (IL-27) is produced in response to inflammation. It is made by activated antigen presenting cells including monocytes, endothelial cells, and dendritic cells. IL-27 consists of a heterodimeric combination of Epstein-Barr virus-induced molecule 3 (EBI3, or IL-27B) non-covalently linked with IL-27 p28 (or IL-27A). It is a regulator of T helper cell development and suppressor of T-cell proliferation. IL-27 has both pro- and anti-inflammatory properties. It can stimulate cytotoxic T cell activity and induce isotype switching in B-cells. It has diverse effects on innate immune cells. It induces monocytes and mast cells to secrete pro-inflammatory cytokines. When infection is present, IL-27 induces naive CD4+ T cells to proliferate and develop Th1 cell responses. As an anti-inflammatory regulator, IL-27 can inhibit Th1 or Th2 responses and restrict the strength and duration of adaptive immune responses. The IL-27 p28 subunit, a 28 kDa glycoprotein belonging to the type I cytokine family, is homologous to IL-12 p35, IL-23 p19, and IL-6. The EBI3 (Epstein-Barr virus-induced molecule 3, or IL-27B) subunit is a 34 kDa glycoprotein containing two fibronectin type III domains, and belongs to the type I cytokine receptor family. It can exist as a homodimer and can also heterodimerize with IL-27 p28 or IL-12 p35 subunit. It is homologous to the p40 subunit of IL-12 and IL-23 and to the extracellular domain of IL-6 R.

    Gen-ID

    50498

    NCBI Accession

    NP_056581

    UniProt

    O35228
Sie sind hier:
Chat with us!